当前位置:首页 - 行情中心 - 仙琚制药(002332) - 财务分析

仙琚制药

(002332)

  

流通市值:112.64亿  总市值:113.17亿
流通股本:9.85亿   总股本:9.89亿

仙琚制药(002332)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.57亿元,每股收益0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益595638.92万元,未分配利润269889.58万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产718666.86万元,负债123027.93万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,037,926,735.624,123,418,584.193,237,459,693.22,118,120,239.92
营业总成本872,354,424.53,489,877,858.412,682,439,708.511,742,468,048.76
营业利润183,979,069.51646,459,105.49545,103,233.87353,521,520.41
利润总额182,129,349.35641,680,548.19543,288,658.99351,559,608.28
净利润156,516,313.26562,118,485.63471,952,130.64300,965,225.61
其他综合收益-30,172,868.9544,869,634.1725,335,128.8270,357,893.31
综合收益总额126,343,444.31606,988,119.8497,287,259.46371,323,118.92
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,521,007,668.763,399,871,398.683,548,177,637.213,457,678,234.1
非流动资产合计3,665,660,896.183,592,963,653.823,454,830,431.823,450,712,226.58
资产总计7,186,668,564.946,992,835,052.57,003,008,069.036,908,390,460.68
流动负债合计1,120,244,305.771,046,909,543.491,122,894,160.411,079,199,758.34
非流动负债合计110,035,041.43115,879,735.58177,146,180.31247,187,114.57
负债合计1,230,279,347.21,162,789,279.071,300,040,340.721,326,386,872.91
归属于母公司股东权益合计5,907,070,224.25,786,121,230.235,657,624,670.165,532,852,968.64
股东权益合计5,956,389,217.745,830,045,773.435,702,967,728.315,582,003,587.77
负债和股东权益合计7,186,668,564.946,992,835,052.57,003,008,069.036,908,390,460.68
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计825,567,894.713,767,192,918.882,832,930,466.891,744,279,974.18
经营活动现金流出小计716,542,893.153,171,710,560.22,343,798,274.391,501,451,886.54
经营活动产生的现金流量净额109,025,001.56595,482,358.68489,132,192.5242,828,087.64
投资活动现金流入小计16,111,727.0554,341,332.5757,651,951.455,374,012.6
投资活动现金流出小计79,871,581.52250,966,728.65168,390,511.07123,810,924.84
投资活动产生的现金流量净额-63,759,854.47-196,625,396.08-110,738,559.67-68,436,912.24
筹资活动现金流入小计500,0001,377,7761,000,0001,000,000
筹资活动现金流出小计15,699,172.59465,225,230.83397,759,794.01346,678,974.74
筹资活动产生的现金流量净额-15,199,172.59-463,847,454.83-396,759,794.01-345,678,974.74
汇率变动对现金及现金等价物的影响-15,771,215.91-13,438,530.5619,881,859.8745,602,989.54
现金及现金等价物净增加额14,294,758.59-78,429,022.791,515,698.69-125,684,809.8
期末现金及现金等价物余额1,644,145,718.811,629,850,960.221,709,795,681.71,582,595,173.21
最新报告期:2024-04-25
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华泰证券代雯,李奕玮0.690.821.012024-04-25
中国银河孙怡,程培0.680.841.012024-04-25
TOP↑